---
title: "Panlong Pharmaceutical: The net profit for the third quarter was 29.6707 million yuan, a decrease of 0.83%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262867288.md"
description: "Panlong Pharmaceutical announced that its revenue for the third quarter was 267 million yuan, a year-on-year increase of 2.24%; net profit was 29.6707 million yuan, a decrease of 0.83%. Revenue for the first three quarters was 841 million yuan, a year-on-year increase of 17.37%; net profit was 89.8059 million yuan, an increase of 0.26%"
datetime: "2025-10-27T10:17:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262867288.md)
  - [en](https://longbridge.com/en/news/262867288.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262867288.md)
---

# Panlong Pharmaceutical: The net profit for the third quarter was 29.6707 million yuan, a decrease of 0.83%

Panlong Pharmaceutical announced that its revenue for the third quarter was 267 million yuan, a year-on-year increase of 2.24%; net profit was 29.6707 million yuan, a decrease of 0.83%. Revenue for the first three quarters was 841 million yuan, a year-on-year increase of 17.37%; net profit was 89.8059 million yuan, an increase of 0.26%

### Related Stocks

- [002864.CN](https://longbridge.com/en/quote/002864.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [While Everyone Chases AI, Pharma Keeps Getting Cheaper](https://longbridge.com/en/news/286650835.md)
- [China's green tech export surge tests US trade stance](https://longbridge.com/en/news/286986953.md)
- [Claritas Rx Strengthens Executive Team with New CRO and Two VP Promotions](https://longbridge.com/en/news/286794376.md)
- [Sensorion Appoints Fred Chereau as Chief Executive Officer](https://longbridge.com/en/news/286719182.md)